TCTR20220302003招募中3 期
Butyrate supplements improve efficacy in patients with moderate to severe chronic spontaneous urticaria, A randomized, double-blind, placebo-controlled trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 Years 至 60 Years（—）
- 性别
- All
入选标准
- •chronic urticaria patients who symptoms do not improve with second generation antihistamine drug
排除标准
- •1. History of butyrate allergy
- •2. Immunocompromised patient , psychiatric , kidney impairment and hepatic impairment patient
- •3. Patient need to take other medicine for chronic urticaria treatment other than second generation antihistamine drug eg. H2 antagonists , leukotriene receptor antagonists, first-generation antihistamine, cyclosporine or omalizumab
- •4. Pregnant
研究者
相似试验
招募中
3 期
Efficacy of butyric acid preparations in patients with hepatocellular carcinoma undergoing chemotherapynresectable hepatocellular carcinomaUnresectable HCCJPRN-jRCTs061230077Otsuka Motoyuki25
已完成
2 期
Effect of butyrate in obesityIRCT20190303042905N2Ahvaz University of Medical Sciences50
已完成
不适用
Butyrate: effect of oral administration in patients with mild hypertensiohigh blood pressure10057166hypertensionNL-OMON49499Academisch Medisch Centrum50
已完成
不适用
Dietary Supplementation With Butyrate in Individuals With Liver Steatosis and Metabolic SyndromeNAFLDMetabolic SyndromeNCT06398522University of Bologna50
Enrolling By Invitation
3 期
MASLD Butyrate Supplementation Treatment Efficacy ReviewMASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseNCT06759363University Medical Center Zvezdara200